Open AccessLongterm experience of magnerot administration in patients with mitral valve prolapse
Author(s) -
А. И. Мартынов,
Е В Акатова
Publication year - 2011
Publication title -
evrazijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2305-0748
pISSN - 2225-1685
DOI - 10.38109/2225-1685-2011-1-13-20
Subject(s) - medicine , mitral valve prolapse , mitral valve , blood pressure , surgery , cardiology
Within 15 years observation 31 patients with prolaps the mitral valve, regularly accepting magnerot, in a dose of 1500 mg a day during all period of observation by 3-month's courses 2 times a year was spent. Features of dynamics of a clinical picture, their interrelation with phenotypic expression of a dysplasia of a connecting tissue, changes of an electrocardiogram, a structure of the valves apparatus of heart, a condition of a vegetative homeostasis, change of level and a daily profile of arterial pressure, a tonus of sympathetic and parasympathetic departments of vegetative nervous system are taped. Against treatment according to the retrospective analysis significant improvement of clinic-tool indicators at all surveyed patients isn't. After regular application of magnesium salt orotate acids authentic improvement of quality of life at patients with prolepses the mitral valve is established.